Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQRT.L Regulatory News (QRT)

  • There is currently no data for QRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Oct 2017 16:31

RNS Number : 8636T
Quarto Group Inc
17 October 2017
 

The Quarto Group, Inc.

 

("Quarto", "the Group" or "the Company") 

 

NOTIFICATION OF TRANSACTION OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMR") OR PERSONS CLOSELY ASSOCIATED WITH THEM ("PCA")

 

 

In accordance with Disclosure Rule 3.1.4R(1), Quarto announces that it has received notice of the following acquisition:

Claire Capeci, Non-Executive Director, acquired 2,500 shares of common stock of US$0.10 each ("Shares") in Quarto at a price of USD1.8347 per Share on 13 October 2017.

Following this transaction, Claire Capeci holds 2,500, Shares representing 0.012% of Quarto's issued share capital.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

 

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

Claire Capeci

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emissions, allowance market participant, auction platorm, auctioneer or auction monitor

a)

Name

THE QUARTO GROUP, INC.

b)

LEI

549300BJ2WPX3QUATW58

4)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

SHARES OF COMMON STOCK OF US$0.10 EACH ("SHARES")

 

Identification Code

US74772E1001

b)

Nature of the transaction

ACQUISITION OF SHARES

c)

Price(s) and volume(s)

Price(s)

Volumes(s)

 

 

USD1.8347

2,500

d)

Aggregated information

 

 

- aggregated volume

 

 

- price

 

e)

Date of transaction

13 October 2017

f)

Place of transaction

LONDON STOCK EXCHANGE (XLON)

(1) Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No. 596/2014 of the European Parliament and of the Council as retards an exemption for certain third countries public bodies and central banks, the indicators of market manipulation, the disclosure thresholds, the competent authority for notification of delays, the permission for trading during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).

 

 

Ends

 

 

  

For further information, please contact:

 

The Quarto Group

Marcus Leaver, CEO

+44 (0)20 7700 9002

Dorothee de Montgolfier, Group Director of Communications

 

About The Quarto Group

 

The Quarto Group (LSE: QRT) is the leading global illustrated book publishing group. Our mission is to make and sell great books that entertain, educate and enrich the lives of adults and children around the world.

 

Quarto creates and owns proprietary content, publishing books from a diverse portfolio of imprints that are creatively independent and expert in developing long-lasting content across specific niches of interest.

 

Quarto sells books across 50 countries and in 39 languages through a variety of traditional and non-traditional channels, while constantly looking for new ways to create and deliver content that people need.

 

Quarto employs over 400 talented people in the US, UK and Hong Kong. The group was founded in London in 1976. It is domiciled in the US and listed on the London Stock Exchange. 

 

For more information, visit quarto.com or follow us on Twitter at @TheQuartoGroup.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKODBPBDDCKD
Date   Source Headline
14th Dec 20232:16 pmRNSResult of Special Meeting
30th Nov 202310:28 amRNSCirc re Proposed Cancellation: Admission of Shares
30th Aug 202310:00 amRNSHalf-year Results
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
6th Jun 202311:41 amRNSPCA Shareholding
24th May 20231:18 pmRNSAnnual Meeting Result
26th Apr 20235:40 pmRNSAnnual Report and Notice of Annual Meeting
31st Mar 202310:11 amRNSFinal Results
18th Oct 20229:21 amRNSDirector Declaration
30th Aug 202210:00 amRNSHalf-year Report
26th Jul 202210:58 amRNSPCA Shareholding
8th Jul 20223:14 pmRNSChange of auditor
6th Jul 20221:50 pmRNSPCA Shareholding
13th Jun 20222:25 pmRNSPCA Shareholding
27th May 20223:19 pmRNSDirector appointment
24th May 20221:00 pmRNSAnnual Meeting Result
5th May 20221:00 pmRNSPCA Shareholding
29th Apr 20222:23 pmRNSHolding(s) in Company
28th Apr 20221:44 pmRNSPCA Shareholding
26th Apr 20227:00 amRNSPCA Shareholding
22nd Apr 20228:21 amRNSPCA Shareholding
19th Apr 20223:07 pmRNSPCA Shareholding
14th Apr 20222:44 pmRNSPCA Shareholding
12th Apr 20223:20 pmRNSPCA Shareholding
12th Apr 202211:32 amRNSAnnual Report and Notice of Annual Meeting
8th Apr 20223:53 pmRNSPCA Shareholding
6th Apr 20223:22 pmRNSPCA Shareholding
4th Apr 20223:51 pmRNSPCA Shareholding
17th Mar 20229:11 amRNSFinal Results
27th Jan 202211:45 amRNSPCA Shareholding
26th Jan 20222:42 pmRNSPCA Shareholding
10th Jan 20221:09 pmRNSPCA Shareholding
7th Jan 20223:52 pmRNSPCA Shareholding
29th Nov 20219:27 amRNSDirector Change (update)
17th Nov 202111:52 amRNSGroup Chief Executive Officer Appointment
11th Oct 20212:56 pmRNSDirector/PDMR Shareholding
17th Aug 202112:24 pmRNSPCA/PDMR Shareholding
16th Aug 20213:08 pmRNSPCA/PDMR Shareholding
10th Aug 20212:52 pmRNSPCA shareholding
3rd Aug 20211:27 pmRNSHalf-year Report
1st Jul 20214:58 pmRNSDirectorate Change
3rd Jun 20214:00 pmRNSDirector Change
25th May 20211:33 pmRNSResult of Annual Meeting
22nd Apr 20217:34 amRNSAnnual Report and Notice of Annual Meeting
22nd Mar 20217:00 amRNSFinal Results
5th Mar 20217:00 amRNSAmalgamation of Stock Lines & Total Voting Rights
17th Feb 20217:00 amRNSAnnouncing new bank facility
13th Oct 20204:09 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSBoard Changes
10th Sep 202010:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.